… design of Ferinject® Assessment in patients with IRon deficiency and chronic Heart Failure (FAIR‐HF) study: a randomized, placebo‐controlled study of intravenous …
SD Anker, JC Colet, G Filippatos… - European journal of …, 2009 - Wiley Online Library
… Another study by Okonko et al.33 confirmed benefits of iv iron loading with iron sucrose in …
and abnormal iron metabolism to 16 weeks of iv iron sucrose or no treatment. Iron therapy was …
and abnormal iron metabolism to 16 weeks of iv iron sucrose or no treatment. Iron therapy was …
Rationale and design of a randomised trial of intravenous iron in patients with heart failure
… The Effectiveness of Intravenous iron treatment versus standard care in patients with heart
failure and iron deficiency (IRONMAN) trial evaluated whether the benefits of intravenous iron …
failure and iron deficiency (IRONMAN) trial evaluated whether the benefits of intravenous iron …
Rationale and design of the intravenous iron for treatment of anemia before cardiac surgery trial
… intravenous (IV) iron therapy thus may improve anemia and therefore patient outcome
following cardiac surgery. We have initiated the intravenous iron for … surgery, IV iron will reduce …
following cardiac surgery. We have initiated the intravenous iron for … surgery, IV iron will reduce …
… of efficacy and safety of ferric carboxymaltose in patients with iron deficiency anaemia and impaired renal function (REPAIR-IDA): rationale and study design
LA Szczech, DB Bregman, RA Harrington… - Nephrology Dialysis …, 2010 - academic.oup.com
… Ferric carboxymaltose (FCM) is a novel IV iron formulation designed to permit larger
infusions compared to currently available IV standards such as Venofer® (iron sucrose). …
infusions compared to currently available IV standards such as Venofer® (iron sucrose). …
Comparative safety of intravenous Ferumoxytol versus Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia: rationale and study design of a randomized …
NF Adkinson, WE Strauss, K Bernard… - Journal of Blood …, 2017 - Taylor & Francis
… However, IV iron treatment has been associated with acute hypersensitivity reactions. The
comparative risk of adverse events (AEs) with IV iron preparations has been assessed by a …
comparative risk of adverse events (AEs) with IV iron preparations has been assessed by a …
Rationale and design of the IRON-AF study: a double-blind, randomised, placebo-controlled study to assess the effect of intravenous ferric carboxymaltose in patients …
… Iron deficiency (ID) is prevalent in patients with AF. Correction of ID in other patient
populations with intravenous iron supplementation has been shown to be a safe, convenient and …
populations with intravenous iron supplementation has been shown to be a safe, convenient and …
Rationale and design of the IRON‐CRT trial: effect of intravenous ferric carboxymaltose on reverse remodelling following cardiac resynchronization therapy
P Martens, M Dupont, J Dauw, F Somers… - ESC Heart …, 2019 - Wiley Online Library
… intravenous iron on reverse remodelling in HFrEF are scarce. Toblli et al. demonstrated that
repeated treatment with iron … was small, used an intravenous iron formulation that is currently …
repeated treatment with iron … was small, used an intravenous iron formulation that is currently …
Supplementation of iron in pulmonary hypertension: rationale and design of a phase II clinical trial in idiopathic pulmonary arterial hypertension
LSGE Howard, GMJ Watson, J Wharton… - Pulmonary …, 2013 - journals.sagepub.com
… We propose that intravenous iron replacement will improve hemodynamics and clinical
outcomes in IPAH. If the data supports a potentially useful therapeutic effect and suggest this …
outcomes in IPAH. If the data supports a potentially useful therapeutic effect and suggest this …
Rationale and design of the IRON-HF study: a randomized trial to assess the effects of iron supplementation in heart failure patients with anemia
L Beck-da-Silva, LE Rohde, AC Pereira-Barretto… - Journal of cardiac …, 2007 - Elsevier
… alone or combination of erythropoietin and intravenous iron. However, the effect of iron
supplementation alone in HF patients with ACD, ferropenic anemia, or both is unknown. …
supplementation alone in HF patients with ACD, ferropenic anemia, or both is unknown. …
[HTML][HTML] Rationale and design of the oral HEMe iron polypeptide Against Treatment with Oral Controlled Release Iron Tablets trial for the correction of anaemia in …
KA Barraclough, E Noble, D Leary, F Brown… - BMC nephrology, 2009 - Springer
… patients), in whom repeated intravenous cannulation is logistically more difficult. Our … iron
versus 2-monthly intravenous iron infusions in 28 PD patients and demonstrated that IV iron …
versus 2-monthly intravenous iron infusions in 28 PD patients and demonstrated that IV iron …
相关搜索
- heart failure intravenous iron
- intravenous iron therapy
- cardiac surgery intravenous iron
- intravenous iron supplementation
- iron crt trial rationale and design
- iron hf study rationale and design
- pre operative intravenous iron
- intravenous iron dextran
- heme iron polypeptide rationale and design
- intravenous iron sucrose
- meta analysis intravenous iron
- treatment of anemia intravenous iron
- reduced ejection fraction intravenous iron
- systematic review intravenous iron
- iron deficiency rationale and design
- intravenous ferric carboxymaltose rationale and design